We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PPL Corporation (PPL) Tops Q1 Earnings and Revenue Estimates
Read MoreHide Full Article
PPL Corporation (PPL - Free Report) , a diversified utility holding company, has operations in the U.S. and the UK. PPL Corp.’s organic growth strategy, systematic investments in utility infrastructure development projects and focus on enhancing customer service are commendable.
Estimate Trend & Surprise History
Investors should note that the first quarter Zacks Consensus Estimate of 66 cents per share has gone down by 4.3% over the last 60 days.
Coming to the earnings surprise, PPL Corp. has surpassed the Zacks Consensus Estimate in the last four trailing quarters, resulting in a positive average surprise of 6.06%.
However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
We have mentioned below some of the vital information from this just-revealed announcement:
Earnings: PPL Corp. reported first quarter 2018 earnings of 74 cents per share, beating the Zacks Consensus Estimate of 66 cents by 12.1%.
Revenue: PPL Corp. posted revenues of $2,126 million in the first quarter, beating the Zacks Consensus Estimate of $1,983 million by 7.2%.
Stock Price: It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this PPL Corporation earnings report later!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
PPL Corporation (PPL) Tops Q1 Earnings and Revenue Estimates
PPL Corporation (PPL - Free Report) , a diversified utility holding company, has operations in the U.S. and the UK. PPL Corp.’s organic growth strategy, systematic investments in utility infrastructure development projects and focus on enhancing customer service are commendable.
Estimate Trend & Surprise History
Investors should note that the first quarter Zacks Consensus Estimate of 66 cents per share has gone down by 4.3% over the last 60 days.
Coming to the earnings surprise, PPL Corp. has surpassed the Zacks Consensus Estimate in the last four trailing quarters, resulting in a positive average surprise of 6.06%.
PPL Corporation Price and EPS Surprise
PPL Corporation Price and EPS Surprise | PPL Corporation Quote
Zacks Rank: Currently, PPL Corp. has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
We have mentioned below some of the vital information from this just-revealed announcement:
Earnings: PPL Corp. reported first quarter 2018 earnings of 74 cents per share, beating the Zacks Consensus Estimate of 66 cents by 12.1%.
Revenue: PPL Corp. posted revenues of $2,126 million in the first quarter, beating the Zacks Consensus Estimate of $1,983 million by 7.2%.
Stock Price: It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this PPL Corporation earnings report later!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>